Glimp-M2

Glimp-M2 is a combination of Metformin Hydrochloride and Glimepiride tablets, prescribed for the management of type 2 diabetes mellitus. It helps lower high blood sugar levels and prevents diabetes-related complications like kidney damage, heart disease, nerve issues, and vision problems.

• Glimepiride (a sulfonylurea) stimulates the pancreas to release more insulin, which helps lower blood glucose.

• Metformin (a biguanide) decreases glucose production in the liver and improves the body’s sensitivity to insulin.

By working together, this combination provides better control of blood sugar, reduces insulin resistance, and supports long-term diabetes care.